as on January 14, 2026 at 2:29 am IST
Day's Low
Day's High
3.63%
Downside
0.27%
Upside
52 Week's Low
52 Week's High
48.73%
Downside
29.21%
Upside
Check Vanda Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$437.9M
EPS (TTM)
-2.6725
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
-27.85
Industry PE ratio
-2.428495575221239
PEG Ratio
-2.42
EBITDA
-113.1M
Revenue (TTM)
212.1M
Profit Margin
-39.70%
Return On Equity TTM
-16.72%
Track how Vanda Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Vanda Pharmaceuticals Inc. in the last 5 years
Lowest (-50.41x)
March 31, 2024
Today (-27.85x)
January 14, 2026
Industry (-2.43x)
January 14, 2026
Highest (87.99x)
September 30, 2022
Today’s Price to Earnings Ratio: -27.85x
Compare market cap, revenue, PE, and other key metrics of Vanda Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $437.9M | -46.78% | -27.85 | -39.70% | |
| BUY | $49.0B | 124.12% | 1236.37 | 1.36% | |
| BUY | $118.1B | 101.07% | 32.37 | 31.35% | |
| NA | $37.0B | NA | 630.17 | 1.38% | |
| BUY | $81.4B | 46.53% | 18.42 | 32.13% |
The Vanda Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vanda Pharmaceuticals Inc. investment value today
Current value as on today
₹1,73,816
Returns
₹73,816
(+73.82%)
Returns from Vanda Pharmaceuticals Inc. Stock
₹69,635 (+69.63%)
Dollar Returns*
₹4,181 (+4.18%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Vanda Pharmaceuticals Inc.. Average target price of $13.62
Get share price movements and forecasts by analysts on Vanda Pharmaceuticals Inc..
What analysts predicted
45.45%UPSIDE
Target Price
$13.62
Current Price
$7.43
Analyzed by
7 Analysts
Target
$13.62
Vanda Pharmaceuticals Inc. target price $13.62, a slight upside of 45.45% compared to current price of $7.43. According to 7 analysts rating.
Investment in Vanda Pharmaceuticals Inc. Shares on INDmoney has grown by 550.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:550.00% versus previous 30 day period
Search interest for Vanda Pharmaceuticals Inc. Stock has increased by 340% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:340% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 31 December
Wed, 03:17 PM
-Vanda Pharmaceuticals shares surged 20% in pre-market after FDA approved its motion-induced vomiting drug, first in over 40 years.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -29.49M → -22.58M (in $), with an average increase of 14.4% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 50.04M → 56.25M (in $), with an average increase of 5.7% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.7% return, outperforming this stock by 32.7%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 74.7% return, outperforming this stock by 4.8%
Price Dip
![]()
In the last 7 days, VNDA stock has moved down by -12.9%
| Organisation | Vanda Pharmaceuticals Inc. |
| Headquarters | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
| Industry | Health Technology |
| CEO | Dr. Mihael H. Polymeropoulos M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Kevin Patrick Moran | Senior VP, CFO & Treasurer |
Mr. Timothy Williams J.D. | Senior VP, General Counsel & Secretary |
Mr. Joakim Wijkstrom | Senior VP & Chief Marketing Officer |
Mr. Gunther Birznieks | Senior Vice President of Business Development |
Mr. Scott L. Howell | Chief People Officer |
Dr. Mihael H. Polymeropoulos M.D. | Founder, President, CEO & Chairman of The Board |
Vanda Pharmaceuticals Inc. share price today is $7.43 as on at the close of the market. Vanda Pharmaceuticals Inc. share today touched a day high of $7.45 and a low of $7.16.
Vanda Pharmaceuticals Inc. share touched a 52 week high of $9.6 on and a 52 week low of $3.81 on . Vanda Pharmaceuticals Inc. stock price today i.e. is closed at $7.43,which is 22.60% down from its 52 week high and 95.05% up from its 52 week low.
Vanda Pharmaceuticals Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Vanda Pharmaceuticals Inc. (VNDA) shares with as little as ₹90.274 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.74 in Vanda Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vanda Pharmaceuticals Inc. share’s latest price of $7.43 as on January 14, 2026 at 2:29 am IST, you will get 1.3459 shares of Vanda Pharmaceuticals Inc.. Learn more about
fractional shares .
Vanda Pharmaceuticals Inc. stock has given -46.78% share price returns and 23.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?